# Stereotactic Radiotherapy of Prostate Cancer With Reduction of Safety Margins

> **NCT06665932** · NA · RECRUITING · sponsor: **University Hospital Ostrava** · enrollment: 100 (estimated)

## Conditions studied

- Prostate Cancer (Adenocarcinoma)

## Interventions

- **PROCEDURE:** Stereotactic radiotherapy

## Key facts

- **NCT ID:** NCT06665932
- **Lead sponsor:** University Hospital Ostrava
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-01
- **Primary completion:** 2027-10-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06665932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06665932, "Stereotactic Radiotherapy of Prostate Cancer With Reduction of Safety Margins". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06665932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*